The DOI matches its Crossref record; 139 of the 139 references it cites were found in a registry or an index.
Application of Nanotechnology in Drug Delivery
Open accessAbstract
This book collects reviews and original articles from eminent experts working in the interdisciplinary arena of nanotechnology use in drug delivery. From their direct and recent experience, the readers can achieve a wide vision on the new and ongoing potentialities of nanotechnology application of drug delivery. Since the advent of analytical techniques and capabilities to measure particle sizes in nanometer ranges, there has been tremendous interest in the use of nanoparticles for more efficient methods of drug delivery. On the other hand, this reference discusses advances in design, optimization, and adaptation of gene delivery systems for the treatment of cancer, cardiovascular, pulmonary, genetic, and infectious diseases, and considers assessment and review procedures involved in the development of gene-based pharmaceuticals.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
Nanocarriers as an emerging platform for cancer therapy
Peer, D., Karp, J. M., Hong, S., Farokhzad, O. C., Margalit, R., & Langer, R. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.387 · Cited by 8,710
Determining the Size and Shape Dependence of Gold Nanoparticle Uptake into Mammalian Cells
Chithrani, B. D., Ghazani, A. A., & Chan, W. C. W. (2006) · Nano Letters · doi:10.1021/nl052396o · Cited by 4,879
Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier
Makadia, H. K., & Siegel, S. J. (2011) · Polymers · doi:10.3390/polym3031377 · Cited by 4,816
Cancer nanotechnology: opportunities and challenges
Ferrari, M. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1566 · Cited by 4,558
Drug Delivery Systems: Entering the Mainstream
Allen, T. M., & Cullis, P. R. (2004) · Science · doi:10.1126/science.1095833 · Cited by 4,552
Drug delivery and nanoparticles: Applications and hazards
de Jong (2008) · International Journal of Nanomedicine · doi:10.2147/ijn.s596 · Cited by 3,848
Factors affecting the clearance and biodistribution of polymeric nanoparticles
Alexis, F., Pridgen, E., Molnar, L. K., & Farokhzad, O. C. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800051m · Cited by 3,699
Strategies in the design of nanoparticles for therapeutic applications
Petros, R. A., & DeSimone, J. M. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd2591 · Cited by 3,651
Poly(ethylene glycol) in Drug Delivery: Pros and Cons as Well as Potential Alternatives
Knop, K., Hoogenboom, R., Fischer, D., & Schubert, U. S. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.200902672 · Cited by 3,533
Knocking down barriers: advances in siRNA delivery
Whitehead, K. A., Langer, R., & Anderson, D. G. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2742 · Cited by 3,115
Clarke, M. F., Dick, J. E., Dirks, P. B., Eaves, C. J., Jamieson, C. H. M., Jones, D. L., Visvader, J., Weissman, I. L., & Wahl, G. M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-3126 · Cited by 3,051
Gold nanoparticles in nanomedicine: preparations, imaging, diagnostics, therapies and toxicity
Boisselier, E., & Astruc, D. (2009) · Chemical Society Reviews · doi:10.1039/b806051g · Cited by 2,842
Nanoparticle-mediated cellular response is size-dependent
Jiang, W., Kim, B. Y. S., Rutka, J. T., & Chan, W. C. W. (2008) · Nature Nanotechnology · doi:10.1038/nnano.2008.30 · Cited by 2,776
Gold nanoparticles in delivery applications☆
GHOSH, P., HAN, G., DE, M., KIM, C., & ROTELLO, V (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.03.016 · Cited by 2,694
Nanoparticles in Medicine: Therapeutic Applications and Developments
Zhang, L., Gu, F., Chan, J., Wang, A., Langer, R., & Farokhzad, O. (2008) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100400 · Cited by 2,657
Gold Nanoparticles Are Taken Up by Human Cells but Do Not Cause Acute Cytotoxicity
Connor, E. E., Mwamuka, J., Gole, A., Murphy, C. J., & Wyatt, M. D. (2005) · Small · doi:10.1002/smll.200400093 · Cited by 2,406
Chithrani, B. D., & Chan, W. C. W. (2007) · Nano Letters · doi:10.1021/nl070363y · Cited by 2,286
A review of stimuli-responsive nanocarriers for drug and gene delivery
Ganta, S., Devalapally, H., Shahiwala, A., & Amiji, M. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.12.017 · Cited by 2,155
Longmire, M., Choyke, P. L., & Kobayashi, H. (2008) · Nanomedicine · doi:10.2217/17435889.3.5.703 · Cited by 2,149
Oligonucleotide-Modified Gold Nanoparticles for Intracellular Gene Regulation
Rosi, N. L., Giljohann, D. A., Thaxton, C. S., Lytton-Jean, A. K. R., Han, M. S., & Mirkin, C. A. (2006) · Science · doi:10.1126/science.1125559 · Cited by 1,988
Size‐Dependent Cytotoxicity of Gold Nanoparticles
Pan, Y., Neuss, S., Leifert, A., Fischler, M., Wen, F., Simon, U., Schmid, G., Brandau, W., & Jahnen‐Dechent, W. (2007) · Small · doi:10.1002/smll.200700378 · Cited by 1,878
Walkey, C. D., & Chan, W. C. W. (2012) · Chem. Soc. Rev. · doi:10.1039/c1cs15233e · Cited by 1,758
Design of polymeric nanoparticles for biomedical delivery applications
Elsabahy, M., & Wooley, K. L. (2012) · Chemical Society Reviews · doi:10.1039/c2cs15327k · Cited by 1,717
Drug delivery systems: An updated review
Tiwari, G., Tiwari, R., Bannerjee, S., Bhati, L., Pandey, S., Pandey, P., & Sriwastawa, B. (2012) · International Journal of Pharmaceutical Investigation · doi:10.4103/2230-973x.96920 · Cited by 1,671
Particle size-dependent organ distribution of gold nanoparticles after intravenous administration
De Jong, W. H., Hagens, W. I., Krystek, P., Burger, M. C., Sips, A. J. A. M., & Geertsma, R. E. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2007.12.037 · Cited by 1,615
Toxicity of Gold Nanoparticles Functionalized with Cationic and Anionic Side Chains
Goodman, C. M., McCusker, C. D., Yilmaz, T., & Rotello, V. M. (2004) · Bioconjugate Chemistry · doi:10.1021/bc049951i · Cited by 1,601
Khlebtsov, N., & Dykman, L. (2011) · Chem. Soc. Rev. · doi:10.1039/c0cs00018c · Cited by 1,584
Huang, X., Jain, P. K., El-Sayed, I. H., & El-Sayed, M. A. (2007) · Nanomedicine · doi:10.2217/17435889.2.5.681 · Cited by 1,503
Nanoparticle-based theranostic agents
Xie, J., Lee, S., & Chen, X. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.07.009 · Cited by 1,422
Gold nanocages covered by smart polymers for controlled release with near-infrared light
Yavuz, M. S., Cheng, Y., Chen, J., Cobley, C. M., Zhang, Q., Rycenga, M., Xie, J., Kim, C., Song, K. H., Schwartz, A. G., et al. (2009) · Nature Materials · doi:10.1038/nmat2564 · Cited by 1,405
ELSAYED, I., HUANG, X., & ELSAYED, M. (2006) · Cancer Letters · doi:10.1016/j.canlet.2005.07.035 · Cited by 1,354
Drug targeting to tumors: Principles, pitfalls and (pre-) clinical progress
Lammers, T., Kiessling, F., Hennink, W. E., & Storm, G. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.09.063 · Cited by 1,324
Nanomedicine—Challenge and Perspectives
Riehemann, K., Schneider, S. W., Luger, T. A., Godin, B., Ferrari, M., & Fuchs, H. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200802585 · Cited by 1,305
Ang, K. K., Berkey, B. A., Tu, X., Zhang, H. Z., Katz, R. L., Hammond, E. H., Fu, K. K., & Milas, L. (2002) · PubMed · Cited by 1,198
Treating metastatic cancer with nanotechnology
Schroeder, A., Heller, D. A., Winslow, M. M., Dahlman, J. E., Pratt, G. W., Langer, R., Jacks, T., & Anderson, D. G. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3180 · Cited by 1,159
Kirpotin, D. B., Drummond, D. C., Shao, Y., Shalaby, M. R., Hong, K., Nielsen, U. B., Marks, J. D., Benz, C. C., & Park, J. W. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4199 · Cited by 1,125
Biologically Active Molecules with a “Light Switch”
Mayer, G., & Heckel, A. (2006) · Angewandte Chemie International Edition · doi:10.1002/anie.200600387 · Cited by 1,119
Sonavane, G., Tomoda, K., & Makino, K. (2008) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2008.07.004 · Cited by 1,100
Alkilany, A. M., Nagaria, P. K., Hexel, C. R., Shaw, T. J., Murphy, C. J., & Wyatt, M. D. (2009) · Small · doi:10.1002/smll.200801546 · Cited by 1,029
Nanoparticles in cancer therapy and diagnosis
Brigger, I., Dubernet, C., & Couvreur, P. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.006 · Cited by 956
Polymeric Micelles in Anticancer Therapy: Targeting, Imaging and Triggered Release
Oerlemans, C., Bult, W., Bos, M., Storm, G., Nijsen, J. F. W., & Hennink, W. E. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0233-4 · Cited by 947
Biological properties of “naked” metal nanoparticles☆
BHATTACHARYA, R., & MUKHERJEE, P. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.03.013 · Cited by 917
MicroRNAs: Synthesis, mechanism, function, and recent clinical trials
Wahid, F., Shehzad, A., Khan, T., & Kim, Y. Y. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2010.06.013 · Cited by 899
Gold Nanoparticles for the Improved Anticancer Drug Delivery of the Active Component of Oxaliplatin
Brown, S. D., Nativo, P., Smith, J.-A., Stirling, D., Edwards, P. R., Venugopal, B., Flint, D. J., Plumb, J. A., Graham, D., & Wheate, N. J. (2010) · Journal of the American Chemical Society · doi:10.1021/ja908117a · Cited by 865
Applications of gold nanoparticles in cancer nanotechnology
Cai, W. (2008) · Nanotechnology, Science and Applications · doi:10.2147/nsa.s3788 · Cited by 851
Glutathione-Mediated Delivery and Release Using Monolayer Protected Nanoparticle Carriers
Hong, R., Han, G., Fernández, J. M., Kim, B.-J., Forbes, N. S., & Rotello, V. M. (2006) · Journal of the American Chemical Society · doi:10.1021/ja056726i · Cited by 817
Gold Nanoparticles of Diameter 1.4 nm Trigger Necrosis by Oxidative Stress and Mitochondrial Damage
Pan, Y., Leifert, A., Ruau, D., Neuss, S., Bornemann, J., Schmid, G., Brandau, W., Simon, U., & Jahnen‐Dechent, W. (2009) · Small · doi:10.1002/smll.200900466 · Cited by 801
Nanoparticle and targeted systems for cancer therapy
Brannon-Peppas, L., & Blanchette, J. O. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.033 · Cited by 796
Gold nanostructures: a class of multifunctional materials for biomedical applications
Cobley, C. M., Chen, J., Cho, E. C., Wang, L. V., & Xia, Y. (2011) · Chem. Soc. Rev. · doi:10.1039/b821763g · Cited by 792
Radiotherapy enhancement with gold nanoparticles
Hainfeld, J. F., Dilmanian, F. A., Slatkin, D. N., & Smilowitz, H. M. (2008) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.60.8.0005 · Cited by 733
Multifunctional Gold Nanoparticles for Diagnosis and Therapy of Disease
Mieszawska, A. J., Mulder, W. J. M., Fayad, Z. A., & Cormode, D. P. (2013) · Molecular Pharmaceutics · doi:10.1021/mp3005885 · Cited by 724
Role of nanotechnology in targeted drug delivery and imaging: a concise review
Koo, O. M., Rubinstein, I., & Onyuksel, H. (2005) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2005.06.004 · Cited by 718
Mechanism of active targeting in solid tumors with transferrin-containing gold nanoparticles
Choi, C. H. J., Alabi, C. A., Webster, P., & Davis, M. E. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914140107 · Cited by 699
Assessment of the In Vivo Toxicity of Gold Nanoparticles
Chen, Y.-S., Hung, Y.-C., Liau, I., & Huang, G. S. (2009) · Nanoscale Research Letters · doi:10.1007/s11671-009-9334-6 · Cited by 695
Hauck, T. S., Ghazani, A. A., & Chan, W. C. W. (2008) · Small · doi:10.1002/smll.200700217 · Cited by 692
Toxicology and clinical potential of nanoparticles
Yildirimer, L., Thanh, N. T. K., Loizidou, M., & Seifalian, A. M. (2011) · Nano Today · doi:10.1016/j.nantod.2011.10.001 · Cited by 676
Kang, B., Mackey, M. A., & El-Sayed, M. A. (2010) · Journal of the American Chemical Society · doi:10.1021/ja9102698 · Cited by 674
The forthcoming applications of gold nanoparticles in drug and gene delivery systems
Pissuwan, D., Niidome, T., & Cortie, M. B. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.12.006 · Cited by 669
Uptake and Intracellular Fate of Surface-Modified Gold Nanoparticles
Nativo, P., Prior, I. A., & Brust, M. (2008) · ACS Nano · doi:10.1021/nn800330a · Cited by 659
Size Matters: Gold Nanoparticles in Targeted Cancer Drug Delivery
Dreaden, E. C., Austin, L. A., Mackey, M. A., & El-Sayed, M. A. (2012) · Therapeutic Delivery · doi:10.4155/tde.12.21 · Cited by 651
Acute toxicity and pharmacokinetics of 13 nm-sized PEG-coated gold nanoparticles
Cho, W.-S., Cho, M., Jeong, J., Choi, M., Cho, H.-Y., Han, B. S., Kim, S. H., Kim, H. O., Lim, Y. T., Chung, B. H., et al. (2009) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2008.12.023 · Cited by 651
Gene Regulation with Polyvalent siRNA−Nanoparticle Conjugates
Giljohann, D. A., Seferos, D. S., Prigodich, A. E., Patel, P. C., & Mirkin, C. A. (2009) · Journal of the American Chemical Society · doi:10.1021/ja808719p · Cited by 637
Liu, Y., Miyoshi, H., & Nakamura, M. (2007) · International Journal of Cancer · doi:10.1002/ijc.22709 · Cited by 620
You, J., Zhang, G., & Li, C. (2010) · ACS Nano · doi:10.1021/nn901181c · Cited by 597
Hirn, S., Semmler-Behnke, M., Schleh, C., Wenk, A., Lipka, J., Schäffler, M., Takenaka, S., Möller, W., Schmid, G., Simon, U., et al. (2011) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2010.12.029 · Cited by 583
Development of the polymer micelle carrier system for doxorubicin
Nakanishi, T., Fukushima, S., Okamoto, K., Suzuki, M., Matsumura, Y., Yokoyama, M., Okano, T., Sakurai, Y., & Kataoka, K. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00341-8 · Cited by 570
Chemical sensing and imaging with metallic nanorods
Murphy, C. J., Gole, A. M., Hunyadi, S. E., Stone, J. W., Sisco, P. N., Alkilany, A., Kinard, B. E., & Hankins, P. (2008) · Chem. Commun. · doi:10.1039/b711069c · Cited by 564
Nanoparticle-assisted Combination Therapies for Effective Cancer Treatment
Hu, C.-M. J., Aryal, S., & Zhang, L. (2010) · Therapeutic Delivery · doi:10.4155/tde.10.13 · Cited by 564
Gold nanoparticles for the development of clinical diagnosis methods
Baptista, P., Pereira, E., Eaton, P., Doria, G., Miranda, A., Gomes, I., Quaresma, P., & Franco, R. (2008) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-007-1768-z · Cited by 548
Autophagy and oxidative stress associated with gold nanoparticles
Li, J. J., Hartono, D., Ong, C.-N., Bay, B.-H., & Yung, L.-Y. L. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.04.014 · Cited by 544
Noble Metal Nanoparticles Applications in Cancer
Conde, J., Doria, G., & Baptista, P. (2012) · Journal of Drug Delivery · doi:10.1155/2012/751075 · Cited by 541
Understanding and Overcoming Major Barriers in Cancer Nanomedicine
Nie, S. (2010) · Nanomedicine · doi:10.2217/nnm.10.23 · Cited by 498
Targeted therapy using nanotechnology: focus on cancer
Sechi, M., Sanna, V., & Pala, N. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s36654 · Cited by 493
Multiple Drug Resistance Mechanisms in Cancer
Baguley, B. C. (2010) · Molecular Biotechnology · doi:10.1007/s12033-010-9321-2 · Cited by 478
Hackenberg, S., Scherzed, A., Kessler, M., Hummel, S., Technau, A., Froelich, K., Ginzkey, C., Koehler, C., Hagen, R., & Kleinsasser, N. (2011) · Toxicology Letters · doi:10.1016/j.toxlet.2010.12.001 · Cited by 473
Surface charge of gold nanoparticles mediates mechanism of toxicity
Schaeublin, N. M., Braydich-Stolle, L. K., Schrand, A. M., Miller, J. M., Hutchison, J., Schlager, J. J., & Hussain, S. M. (2011) · Nanoscale · doi:10.1039/c0nr00478b · Cited by 470
Gold nanoparticle platforms as drug and biomacromolecule delivery systems
Duncan, B., Kim, C., & Rotello, V. M. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.06.004 · Cited by 469
The Roles of Therapy-Induced Autophagy and Necrosis in Cancer Treatment
Amaravadi, R. K., & Thompson, C. B. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1595 · Cited by 465
Cell selective response to gold nanoparticles
Patra, H. K., Banerjee, S., Chaudhuri, U., Lahiri, P., & Dasgupta, A. K. (2007) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2007.03.005 · Cited by 456
Photoregulated Release of Caged Anticancer Drugs from Gold Nanoparticles
Agasti, S. S., Chompoosor, A., You, C.-C., Ghosh, P., Kim, C. K., & Rotello, V. M. (2009) · Journal of the American Chemical Society · doi:10.1021/ja900591t · Cited by 434
Introduction to nanotechnology and its applications to medicine
Silva, G. A. (2004) · Surgical Neurology · doi:10.1016/j.surneu.2003.09.036 · Cited by 383
Arnida, Malugin, A., & Ghandehari, H. (2010) · Journal of Applied Toxicology · doi:10.1002/jat.1486 · Cited by 378
Resistance mechanisms associated with altered intracellular distribution of anticancer agents
Larsen, A. K., Escargueil, A. E., & Skladanowski, A. (2000) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(99)00073-x · Cited by 369
Co-Delivery of siRNA and An Anticancer Drug for Treatment of Multidrug-Resistant Cancer
Saad, M., Garbuzenko, O. B., & Minko, T. (2008) · Nanomedicine · doi:10.2217/17435889.3.6.761 · Cited by 367
Tat Peptide as an Efficient Molecule To Translocate Gold Nanoparticles into the Cell Nucleus
de la Fuente, J. M., & Berry, C. C. (2005) · Bioconjugate Chemistry · doi:10.1021/bc050033+ · Cited by 342
Tumor targeting using anti-her2 immunoliposomes
Park, J. W., Kirpotin, D. B., Hong, K., Shalaby, R., Shao, Y., Nielsen, U. B., Marks, J. D., Papahadjopoulos, D., & Benz, C. C. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00315-7 · Cited by 335
Lu, W., Xiong, C., Zhang, G., Huang, Q., Zhang, R., Zhang, J. Z., & Li, C. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1480 · Cited by 322
Nanoparticle therapeutics: an emerging treatment modality for cancer
Davis, M. E., Chen, Z. (., & Shin, D. M. (2009) · Nanoscience and Technology · doi:10.1142/9789814287005_0025 · Cited by 321
Gold nanoparticles in cancer therapy
Lim, Z.-Z. J., Li, J.-E. J., Ng, C.-T., Yung, L.-Y. L., & Bay, B.-H. (2011) · Acta Pharmacologica Sinica · doi:10.1038/aps.2011.82 · Cited by 314
Nanomaterials for Cancer Therapy and Imaging
Bae, K. H., Chung, H. J., & Park, T. G. (2011) · Molecules and Cells · doi:10.1007/s10059-011-0051-5 · Cited by 313
Gao, H., Yang, Z., Zhang, S., Cao, S., Shen, S., Pang, Z., & Jiang, X. (2013) · Scientific Reports · doi:10.1038/srep02534 · Cited by 306
(2000) · PubMed · Cited by 295
Chaabane, W., User, S. D., El-Gazzah, M., Jaksik, R., Sajjadi, E., Rzeszowska-Wolny, J., & Łos, M. J. (2013) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-012-0205-y · Cited by 282
Dreaden, E. C., Mwakwari, S. C., Sodji, Q. H., Oyelere, A. K., & El-Sayed, M. A. (2009) · Bioconjugate Chemistry · doi:10.1021/bc9002212 · Cited by 268
Gannon, C. J., Patra, C. R., Bhattacharya, R., Mukherjee, P., & Curley, S. A. (2008) · Journal of Nanobiotechnology · doi:10.1186/1477-3155-6-2 · Cited by 261
Sapra, P., & Allen, T. M. (2002) · PubMed · Cited by 242
Therapeutic Nanoparticles to Combat Cancer Drug Resistance
Hu, C.-M., & Zhang, L. (2009) · Current Drug Metabolism · doi:10.2174/138920009790274540 · Cited by 223
Gold Nanoparticles Induce Oxidative Damage in Lung Fibroblasts In Vitro
Li, J. J., Zou, L., Hartono, D., Ong, C. ‐., Bay, B. ‐., & Lanry Yung, L. ‐. (2008) · Advanced Materials · doi:10.1002/adma.200701853 · Cited by 219
Drug Delivery Nanoparticles Formulation and Characterization
(2016) · CRC Press eBooks · doi:10.3109/9781420078053 · Cited by 205
Noninvasive radiofrequency ablation of cancer targeted by gold nanoparticles
Cardinal, J., Klune, J. R., Chory, E., Jeyabalan, G., Kanzius, J. S., Nalesnik, M., & Geller, D. A. (2008) · Surgery · doi:10.1016/j.surg.2008.03.036 · Cited by 201
Cyclodextrin-covered gold nanoparticles for targeted delivery of an anti-cancer drug
Park, C., Youn, H., Kim, H., Noh, T., Kook, Y. H., Oh, E. T., Park, H. J., & Kim, C. (2009) · Journal of Materials Chemistry · doi:10.1039/b816209c · Cited by 200
DNA Damage and P53-Mediated Growth Arrest in Human Cells Treated with Platinum Nanoparticles
Asharani, P., Xinyi, N., Hande, M. P., & Valiyaveettil, S. (2010) · Nanomedicine · doi:10.2217/nnm.09.85 · Cited by 198
The Role of ATP Binding Cassette Transporters in Tissue Defense and Organ Regeneration
Huls, M., Russel, F. G. M., & Masereeuw, R. (2009) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.132225 · Cited by 183
Stability of Gold Nanoparticle‐Bound DNA toward Biological, Physical, and Chemical Agents
Han, G., Martin, C. T., & Rotello, V. M. (2006) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2005.00324.x · Cited by 171
Gold-doxorubicin nanoconjugates for overcoming multidrug resistance
Gu, Y.-J., Cheng, J., Man, C. W.-Y., Wong, W.-T., & Cheng, S. H. (2012) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2011.06.005 · Cited by 171
Systematic Evaluation of Nanomaterial Toxicity: Utility of Standardized Materials and Rapid Assays
Harper, S. L., Carriere, J. L., Miller, J. M., Hutchison, J. E., Maddux, B. L. S., & Tanguay, R. L. (2011) · ACS Nano · doi:10.1021/nn200546k · Cited by 169
Long-term tracking of cells using inorganic nanoparticles as contrast agents: are we there yet?
Taylor, A., Wilson, K. M., Murray, P., Fernig, D. G., & Lévy, R. (2012) · Chemical Society Reviews · doi:10.1039/c2cs35031a · Cited by 166
Susa, M., Iyer, A. K., Ryu, K., Choy, E., Hornicek, F. J., Mankin, H. J., Milane, L. S., Amiji, M. M., & Duan, Z. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010764 · Cited by 162
Conde, J., Tian, F., Hernández, Y., Bao, C., Cui, D., Janssen, K., Ibarra, M. R., Baptista, P. V., Stoeger, T., & de la Fuente, J. M. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.06.041 · Cited by 154
Amphiphilic polymer-coated hybrid nanoparticles as CT/MRI dual contrast agents
Kim, D., Yu, M. K., Lee, T. S., Park, J. J., Jeong, Y. Y., & Jon, S. (2011) · Nanotechnology · doi:10.1088/0957-4484/22/15/155101 · Cited by 150
Gold Nanoparticles: Promising Nanomaterials for the Diagnosis of Cancer and HIV/AIDS
Kumar, A., Boruah, B. M., & Liang, X. (2011) · Journal of Nanomaterials · doi:10.1155/2011/202187 · Cited by 139
Ganesh, S., Iyer, A. K., Weiler, J., Morrissey, D. V., & Amiji, M. M. (2013) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2013.29 · Cited by 137
Light-Triggered Molecule-Scale Drug Dosing Devices
McCoy, C. P., Rooney, C., Edwards, C. R., Jones, D. S., & Gorman, S. P. (2007) · Journal of the American Chemical Society · doi:10.1021/ja073053q · Cited by 126
Nanocarriers for Anticancer Drugs - New Trends in Nanomedicine
Drbohlavová, J., Chomoucká, J., Adam, V., Ryvolová, M., Eckschlager, T., Hubálek, J., & Kizek, R. (2013) · Current Drug Metabolism · doi:10.2174/1389200211314050005 · Cited by 121
Han, G., Chari, N. S., Verma, A., Hong, R., Martin, C. T., & Rotello, V. M. (2005) · Bioconjugate Chemistry · doi:10.1021/bc050173j · Cited by 120
Cellular Uptake of Gold Nanoparticles Passivated with BSA−SV40 Large T Antigen Conjugates
Ryan, J. A., Overton, K. W., Speight, M. E., Oldenburg, C. N., Loo, L., Robarge, W. P., Franzen, S., & Feldheim, D. L. (2007) · Analytical Chemistry · doi:10.1021/ac0715524 · Cited by 120
Chattopadhyay, N., Fonge, H., Cai, Z., Scollard, D. A., Lechtman, E., Done, S. J., Pignol, J., & Reilly, R. M. (2012) · Molecular Pharmaceutics · doi:10.1021/mp300016p · Cited by 115
In Vivo toxicity assessment of gold nanoparticles in Drosophila melanogaster
Pompa, P. P., Vecchio, G., Galeone, A., Brunetti, V., Sabella, S., Maiorano, G., Falqui, A., Bertoni, G., & Cingolani, R. (2011) · Nano Research · doi:10.1007/s12274-011-0095-z · Cited by 111
Conde, J., Rosa, J., de la Fuente, J. M., & Baptista, P. V. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2012.12.015 · Cited by 97
Conde, J., Larguinho, M., Gaspar‐Cordeiro, A., Raposo, L. R., Costa, P. M., Santos, S., Diniz, M., Fernandes, A. R., & Baptista, P. V. (2013) · Nanotoxicology · doi:10.3109/17435390.2013.802821 · Cited by 93
Five Years of siRNA Delivery: Spotlight on Gold Nanoparticles
Lytton‐Jean, A. K. R., Langer, R., & Anderson, D. G. (2011) · Small · doi:10.1002/smll.201100761 · Cited by 93
Use of Nanotechnology to Develop Multi-Drug Inhibitors for Cancer Therapy
Gowda, R., Jones, N. R., Banerjee, S., & Robertson, G. P. (2013) · Journal of Nanomedicine & Nanotechnology · doi:10.4172/2157-7439.1000184 · Cited by 92
Light‐Regulated Release of DNA and Its Delivery to Nuclei by Means of Photolabile Gold Nanoparticles
Han, G., You, C., Kim, B., Turingan, R. S., Forbes, N. S., Martin, C. T., & Rotello, V. M. (2006) · Angewandte Chemie · doi:10.1002/ange.200600214 · Cited by 90
Carbon Nanomaterials: Efficacy and Safety for Nanomedicine
Yamashita, T., Yamashita, K., Nabeshi, H., Yoshikawa, T., Yoshioka, Y., Tsunoda, S., & Tsutsumi, Y. M. (2012) · Materials · doi:10.3390/ma5020350 · Cited by 81
Kao, H.-W., Lin, Y.-Y., Chen, C., Chi, K., Tien, D., Hsia, C.-C., Lin, M.-H., & Wang, H. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.04.002 · Cited by 79
Wang, J., Yao, K., Wang, C., Tang, C., & Jiang, X. (2013) · Journal of Materials Chemistry B · doi:10.1039/c3tb20100g · Cited by 75
Nanoparticles in Molecular Diagnostics
Baptista, P. V., Dória, G., Quaresma, P., Cavadas, M. A. S., Neves, C., Gomes, I., Eaton, P. J., Pereira, E., & Franco, R. (2011) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-416020-0.00011-5 · Cited by 70
Dendrimers as Biopharmaceuticals: Synthesis and Properties
Villalonga‐Barber, C., Micha‐Screttas, M., Steele, B. R., Georgopoulos, A., & Demetzos, C. (2008) · Current Topics in Medicinal Chemistry · doi:10.2174/156802608785849012 · Cited by 65
Cancer stem cell theory: therapeutic implications for nanomedicine
Huang, J., Wang, X., Wu, & Wang (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s38641 · Cited by 65
Clift, M. J. D., & Stone, V. (2012) · Theranostics · doi:10.7150/thno.4545 · Cited by 65
Toxicity of citrate-capped AuNPs: an in vitro and in vivo assessment
Sabella, S., Brunetti, V., Vecchio, G., Galeone, A., Maiorano, G., Cingolani, R., & Pompa, P. P. (2011) · Journal of Nanoparticle Research · doi:10.1007/s11051-011-0590-x · Cited by 54
Yazid, H., Adnan, R., Hamid, S. A., & Farrukh, M. A. (2010) · TURKISH JOURNAL OF CHEMISTRY · doi:10.3906/kim-0912-379 · Cited by 54
CABRAL, R. M., & Baptista, P. V. (2013) · Nano LIFE · doi:10.1142/s179398441330001x · Cited by 50
Inhibiting metastasis of breast cancer cells in vitro using gold nanorod-siRNA delivery system
Zhang, W., Meng, J., Ji, Y., Li, X., Kong, H., Wu, X., & Xu, H. (2011) · Nanoscale · doi:10.1039/c1nr10573f · Cited by 47
Nanomaterials for reversion of multidrug resistance in cancer: a new hope for an old idea?
Conde, J., de la Fuente, J. M., & Baptista, P. V. (2013) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00134 · Cited by 43
Porous Hollow Gold Nanoparticles for Cancer SERS Imaging
Huang, C. W., Hao, Y. W., Nyagilo, J. O., Davé, D. P., Xu, L. F., & Sun, X. K. (2010) · Journal of nano research · doi:10.4028/www.scientific.net/jnanor.10.137 · Cited by 25
Ryou, S.-M., Park, M., Kim, J., Jeon, C. O., Yun, C.-H., Han, S. H., Kim, S. W., Lee, Y., Kim, S., Han, M. S., et al. (2011) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2011.07.037 · Cited by 21
Nanotechnology for Cancer Diagnostics and Therapy – An Update on Novel Molecular Players
Fernandes, A. R., & Baptista, P. V. (2014) · Current Cancer Therapy Reviews · doi:10.2174/157339470903140220144703 · Cited by 8
Cited by
Therapeutic efficacy of nanoparticles and routes of administration
Chenthamara, D., Subramaniam, S., Ramakrishnan, S. G., Krishnaswamy, S., Essa, M. M., Lin, F.-H., & Qoronfleh, M. W. (2019) · Biomaterials Research · doi:10.1186/s40824-019-0166-x · Cited by 1,055
Plant Exosome-like Nanovesicles: Emerging Therapeutics and Drug Delivery Nanoplatforms
Dad, H. A., Gu, T.-W., Zhu, A.-Q., Huang, L.-Q., & Peng, L.-H. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2020.11.030 · Cited by 745
Polymeric nanoparticles: Promising platform for drug delivery
El-Say, K. M., & El-Sawy, H. S. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.06.052 · Cited by 608
Microparticles, Microspheres, and Microcapsules for Advanced Drug Delivery
Lengyel, M., Kállai-Szabó, N., Antal, V., Laki, A. J., & Antal, I. (2019) · Scientia Pharmaceutica · doi:10.3390/scipharm87030020 · Cited by 598
Khandel, P., Yadaw, R. K., Soni, D. K., Kanwar, L., & Shahi, S. K. (2018) · Journal of Nanostructure in Chemistry · doi:10.1007/s40097-018-0267-4 · Cited by 452
Metadata
- Venue
- InTech eBooks
- Publisher
- InTech
- Published
- 2014-07-25
- OpenAlex
- W2479631244
- Cited by
- 266
- References
- 139
- FWCI
- 6.91
- Type
- book
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.